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ABSTRACT 
Background and purpose:There may be potential to reduce the number of items assessed in 
the Barthel Index (BI) and shortened versions of the BI have been described.  We sought to 
collate all existing short form BI (SF-BI) and perform a comparative validation using clinical 
trial data.  
Methods: We performed a systematic review across multidisciplinary electronic databases to 
find all published SF-BI.  Our validation used the Virtual International Stroke Trials Archive 
(VISTA) resource.  We describe concurrent validity (agreement of each SF-BI with BI); 
convergent and divergent validity (agreement of each SF-BI with other outcome measures 
available in the dataset); predictive validity (association of prognostic factors with SF-BI 
outcomes) and content validity (item correlation and exploratory factor analyses). 
Results: From 3546 titles, we found eight papers describing six differing SF-BI.  Using acute 
trial data (n=8852), internal reliability suggested redundancy in BI (Cronbach α:0.96).   
Each SF-BI demonstrated a strong correlation with BI, modified Rankin Scale (mRS), 
National Institutes of Health Stroke Scale (NIHSS) (all ρ≥0.83; p<0.001).  Using 
rehabilitation trial data (n=332) SF-BI demonstrated modest correlation with quality of life 
measures SIS and EQ-5D (ρ≥0.50, p<0.001).  Pre-specified prognostic factors were 
associated with SF-BI outcomes (all p<0.001).  Our factor analysis described a three factor 
structure and item reduction suggested an optimal 3-item SF-BI comprising bladder control, 
transfer and mobility items in keeping with one of the 3-item SF-BI previously described in 
the literature.   
Conclusion:There is redundancy in the original BI; we have demonstrated internal and 
external validity of a 3-item SF-BI that should be simple to use. 
  
INTRODUCTION 
The Barthel Index (BI) is a ten-item measure of basic activities of daily living (ADL).1  The BI 
is the second most commonly used functional assessment scale in stroke trials and the most 
commonly used ADL assessment in adult rehabilitation.2,3  BI quantifies ADL in an ordinal, 
hierarchical scale that ranges from 0-20 or 0-100 depending on the scoring used.4  BI is 
recommended as an outcome measure by various professional societies and guidelines.3  BI 
has proven prognostic utility5, it is used in clinical practice to inform rehabilitation and care 
planning and it is used in research both to describe outcomes and as case-mix adjuster.  
The BI has proven a useful scale but there is scope for improvement, for example “floor and 
ceiling” effects of BI scoring are well described.6  For any assessment there is a trade-off 
between the time and effort required for testing and the validity of the data acquired7.  
Although administration time for BI assessment is modest, there is still opportunity cost, 
particularly in busy clinical settings.8   
Issues with time taken to complete a scale are important to the assessor (longer time spent 
in assessment gives less time for other clinical activity) and is important to the patient (test 
burden is a particular issue in the context of acute stroke).  These issues will be more 
apparent in patients with physical, cognitive or communication difficulties, yet this is exactly 
the population that require robust assessment of function.  In the NHS England and Wales 
National Stroke Audit, completion rate of BI measures was approximately 60%, with lack of 
time cited as the reason for poor completion.9  The problem is not unique to assessment of 
BI, in large registries completion of the modified Rankin Scale (mRS) was around 75% with 
lesser completion in those with more severe impairments10.  In a rehabilitation study, 
completion of the Stroke Impact Scale was limited with potential to bias results11.  
In this situation, the ideal would be a shortened form of the BI that offered prompt 
assessment without sacrificing clinical properties.  The high internal reliability of the BI 
suggests that certain component items of BI are redundant and there is potential to 
condense the scale.6   
We sought to describe and compare properties of published short form versions of BI (SF-
BI), using a two stage approach; first systematically searching the literature for SF-BI and 
then validating and comparing the various forms using an independent dataset. 
  
Methods 
Systematic review 
Our primary question for the systematic review was:which items are included in short form 
versions of BI for use in patients in stroke?  As the purpose of the search was to find SF-BI 
we did not perform quantitative summary analyses or quality assessment of primary papers. 
We devised a focussed search strategy using validated search terms across multidisciplinary 
electronic databases.  After initial scoping searches, we opted to use a concepts-based 
approach with search strings based on concepts of “Barthel Index/ADL-assessment” and 
“short forms/psychometric properties of scales”.  Search strings were based on MeSH and 
other controlled vocabulary.(Supplementary materials I)  
We searched across three electronic databases (Medline (OVID), Embase (OVID) and Health 
and Psychosocial Instruments (OVID)) all from inception to December 2015.  We used 
citation searching (backwards searching) and assessed all papers that had cited the index 
paper (forwards searching).   
We included any paper that described a shortened (less than ten items) version of the BI.  
We limited to studies of patients with stroke or brain injury but operated no restrictions with 
respect to language, date or study design.    
Titles and abstracts generated from the electronic database searches were screened for 
relevance.  Irrelevant titles and abstracts were excluded and full-text articles inspected to 
determine eligibility.  As a test of external validity, we pre-selected two studies12,13 relevant 
to the study question from a previous review of BI properties6 and we assessed whether the 
search included these studies. 
We extracted details of studies meeting inclusion criteria to a pre-specified proforma.  We 
described the items included in the short form, the derivation sample, the method used for 
item reduction and any validation.  We included data in the primary publications and 
supplementary materials but did not contact study authors for additional detail.  
We followed, where appropriate, PRISMA best practice guidance for design, conduct and 
reporting of this systematic review.14  All aspects of title selection, assessment and data 
extraction were performed by two independent researchers trained in systematic review 
(TQ, MTR).  The review protocol was registered with Research Registry 
(www.researchregistry.com, researchregistry1213).  
Validation of Short Form Barthel Index 
Validity is the extent to which a rating scale measures what it purports to measure.15 We 
used multiple, complementary, approaches to validation of each of the SF-BI identified by 
literature searching, all pre-specified and described in our protocol.  Based on peer review 
advice, we added a further assessment of divergent validity.  For these analyses we utilised 
the Virtual International Stroke Trial Archive (VISTA) resource.  All analyses used SAS 
version 9.4 (SAS Institute, Cary USA) software. 
VISTA is a not-for-profit repository for stroke trial data, containing study quality, 
anonymized individual patient level data on thousands of participants.  These data have 
been used to investigate novel hypotheses including analyses of stroke assessment scale 
properties.16,17  We selected all patient-level data that contained BI along with any other 
functional outcome measure.  Within VISTA we had access to datasets from acute stroke 
settings and rehabilitation studies.  We ensured that studies included in our VISTA datasets 
had not been used to develop any of the published SF-BI found on literature searching.  A-
priori we decided to treat data from acute stroke trials and from rehabilitation studies 
separately, as we believed they may have differing outcome measures and differing case-
mix of participants. 
We described clinical and demographic features of the acute and rehabilitation datasets.  
Where data were collected at more than one time-point, we used the time-point that gave 
largest dataset.  We assessed internal consistency of standard (ten item) BI using 
Cronbach’s alpha.  
 
Concurrent, convergent and divergent validity:We described concurrent validity by 
assessing the agreement (Spearman’s rank correlation) of each SF-BI with the standard BI 
and with the various other short forms.  We assessed convergent validity by describing 
agreement with other functional outcome assessments.  After initial scoping of available 
data, our chosen comparator outcomes for acute data were modified Rankin Scale (mRS) 
and National Institutes of Health Stroke Scale (NIHSS).  For rehabilitation data, we used the 
health related quality of life tools five domain EuroQOL (EQ-5D and visual analogue scale 
[VAS]) and the Stroke Impact Scale (SIS).  EQ-5D data were transformed into a single index 
using the Europe-VAS dataset.  For divergent validity we described association with an 
aphasia scale, the Sheffield Screening Test for Acquired Language Disorders.  We 
hypothesised that agreement with SF-BI would be greater for the other activity/impairment 
level scales (mRS, NIHSS), less for the quality of life scales (EQ-5D, VAS, SIS) and lowest for 
the aphasia scale.  
 
Predictive validity:We used ordinal univariate regressions to assess association of each 
SF-BI with, where data were available, clinical and demographic features known to influence 
stroke outcome (age, baseline stroke severity, physiological variables, comorbidity, prior 
stroke and use of thrombolytic therapy).  In the first analysis we described cross-sectional 
association of point change in various SF-BI with clinical and demographic factors known to 
be associated with outcome.  In the second analysis we described odds of a point change in 
SF-BI associated with unit change in NIHSs or mRS at 90-day follow-up. 
 
Content validity:As a final test we explored the most discriminating BI items in the acute 
VISTA dataset.  We performed exploratory factor analysis to suggest a minimum number of 
items for a short form and further analyses to determine the optimal items for this short 
form.  Due to the larger sample size, factor analysis was restricted to the acute dataset.  We 
first described correlation, using Spearman’s rho, for each BI item relative to the total score.  
Correlations between individual items were explored to investigate item redundancy and 
exploratory factor analysis was performed to investigate the underlying structure of the BI.  
As a final test of content validity we derived a short form from the VISTA data.  We used 
exploratory factor analysis to outline the minimum number of factors needed and then used 
a stepwise selection process sequential removing the poorest performing individual item 
(based on correlation with total BI and Cronbach’s alpha) and comparing properties to find 
the three items within VISTA that had optimal properties.  We compared the resulting VISTA 
derived short form (herein referred to as SF-BI VISTA) with the short forms identified from 
the systematic review. 
 
Results 
Systematic review:From 3546 titles, we found eight12,13,18-23 titles describing six differing 
short forms of the BI.(PRISMA diagram, Supplementary materials II)  Some of the papers 
were validations of previously described scores20,19, although it was not always clear in the 
text if the SF-BI presented was derivation or validation.  The validity of our search was 
proven as our two pre-specified papers12,13 were included in the original search results.   
The short forms differed in the number of included items, the nature of the items included 
and in the methodology used for item reduction.  The short forms included a variety of BI 
items and all BI items were included in at least one of the short forms.  Ability to perform 
transfers was a feature in most of the SF-BI, while dressing was included in only one SF-
BI.(Figure 1)  The short forms described by Bohannon and Ellul required additional 
computation to assign a total score13,19 and we added these formulae to correct the score 
before any of the validation analyses. 
The authors used various approaches to derivation of the SF-BI and methods of derivation 
and validation were not consistently described.  One of the papers described a short form 
with no reference to derivation or validation.23  Only the 5-item SF-BI described by Hobart12 
and 3-item SF-BI described by Ellul had robust derivation, multi-modal validation and further 
validation of the unmodified scale in an external dataset.(Table 1)  
 
Validation analyses:The VISTA database had 8852 acute strokes with a recorded 
measurement of BI at 90 days (919 ICH, 7933 ischaemic), 8493 of whom had a complete BI 
measurement for day 30.  The rehabilitation dataset had 332 participants with a recording of 
BI at baseline.  For these rehabilitation studies, “baseline” assessments were predominantly 
at four weeks post ictus.  The included patients were broadly representative of trial 
populations, mean age 68.1 years (SD:12.4), n=3943 (44.5%) female for the acute dataset 
and 65.7 years (SD:11.0), n=107 (32%) female for the rehabilitation dataset.  Both 
populations had prevalent comorbidity for example, ischaemic heart disease and diabetes 
mellitus.(Supplementary materials III,IV) 
There was a spread of BI scores across both datasets, for acute data median BI day 90 was 
80 (IQR:60), for rehabilitation data, median BI baseline was 75 (IQR:35).  Internal 
consistency for complete BI was high in the acute dataset, with α:0.95 (BI day 30 and 90). 
For the rehabilitation dataset α:0.85 (BI baseline).  
In both datasets we described concurrent validity as the correlation of each individual BI 
item with the full scale.(Table 2, Supplementary materials V) 
We assessed convergent validity of each SF-BI in our datasets.  Agreement of SF-BI with full 
BI was excellent in both datasets.(Table 3)  Each SF-BI showed significant (p<0.0001) 
correlations with all our chosen outcome measures.  For acute data correlations with mRS 
and NIHSS were strong.  SF-BI at baseline showed weaker correlation with quality of life 
measures in the rehabilitation dataset, albeit correlations were roughly equivalent to those 
seen for full BI.  Correlations were strongest for SIS, a measure that includes assessment of 
ADL, and weakest for the VaS.  Correlations with the aphasia measure (divergent validity) 
were weak.(Table 3) 
Our assessment of predictive validity was limited to the acute dataset, due to small numbers 
of common follow-up assessments in the rehabilitation dataset.  On ordinal univariate 
analyses, several factors known to predict outcome were independently associated 
(p<0.0001) with SF-BI.(Supplementary materials VI) Each SF-BI was independently 
predictive of mRS at day 90 and NIHSS at day 90 in univariate ordinal 
regressions.(Supplementary material VII) This association persisted when adjusting for the 
relevant clinical attributes suggested in univariate analysis (age,sex,stroke type).(Table 4)   
As a test of content validity we derived a correlation matrix, between item analyses 
suggested redundancy with correlations of >0.7 for most individual items.(Supplementary 
materials V).  Exploratory factor analysis identified two independent factors within BI, with a 
potential third cross-loading factor.(Supplementary materials VIII)  Based on this, we 
derived a 3-item SF-BI and for comparison a 5-item SF-BI.  The optimal 3-item scale 
comprised bladder control, transfer and mobility i.e. the items used in Ellul.13  The optimal 5-
item scale compromised dressing, toileting, transfers, mobility, stairs.  
As a post-hoc exploratory analysis we compared the utility of a simple sum of the three 
items, as used in SF-VISTA, and compared to the scores generated using the formulae 
suggested by Ellul.13  In the context of our validation analyses we found that, compared to 
the Ellul formula, there was no evidence that the simple sum score used in SF-VISTA 
correlated less well with other BI-derived scales (Table 3) or was less strongly associated 
with mRS or NIHSS (Table 4).  
Discussion  
Using systematic review and secondary analyses of existing data we have described the 
validity of various published short form versions of the BI.  Our review of the literature 
found various SF-BI with differing number of items, differing components included and 
differing scoring.  The derivation and validation of these scales was inconsistently described.  
However, our independent validation using a large dataset confirmed the potential item 
redundancy within BI (high internal reliability) and suggested utility of a short form (the 
form originally described by Bohannon18,19 and Ellul13) comprising three easily assessed 
variables. 
 
Based on our analyses we would recommend a 3-item SF-BI that assesses bladder control, 
mobility and transfers.  We feel this offers parsimony while still capturing key aspects of 
ADL.  Comparing the existent three, four and five item SF-BI, there was no obvious increase 
in our measures of validity with increasing number of items.  We note that ability to perform 
transfers appeared in almost all the short forms and suspect that any short form should 
include this item.  The component items of the 3-item SF-BI should be relatively simple to 
score and our post-hoc analysis suggests that item scored can be added to give a total score 
without the need for additional calculations. 
 
We chose to validate existing SF-BI rather than focus on creating our own de-novo SF-BI.  
A-priori we suspected that various SF-BI would be available and we recognise the difficulty 
of establishing a novel assessment into routine use.24  We designed analyses that assessed 
concurrent, convergent, predictive and content validity.  The ideal for convergent validity 
would have been another ADL assessment.  Such data were not available within VISTA, this 
concurs with our previous findings that BI is the most prevalent ADL assessment in trials 
and other measures are infrequently used.2  We assessed agreement with similar outcome 
assessment scales (mRS and NIHSS) and with assessments that measure differing 
constructs (EQ-5D, Sheffield Test).  Assessing BI against mRS and NIHSS is in keeping with 
previous work looking at stroke outcome properties.25  The weaker agreement with the 
aphasia and quality of life scales supports the short forms as tools describing ADL rather 
than generic measures of stroke recovery. 
 
We feel confident of the properties of the 3-item SF-BI that we recommend, as it performed 
well in our validation analyses and previous derivation and validation studies have been 
described.  We note also that for some of our convergent validity analyses, the short forms 
performed better than the full BI.  This may suggest that as a prognostic tool or case-mix 
adjuster, baseline short forms of the BI may be preferable to the full assessment.  
 
In creating a shorter version of an existing scale there is a compromise between ease of use 
and richness of data captured.  Standard BI is already a reasonably short assessment scale, 
in fact various groups have suggested that BI lacks granularity and have proposed additional 
items be added to the scoring or the scale. 26,27  We do not envisage the SF-BIs being used 
for individual clinical assessment, rather we think the short scales will have utility in large 
scale audit, epidemiology and clinical research.  Time required for testing is a major factor in 
determining acceptability of a scale to therapists.28  The SF-BIs described in the literature 
had a minimum of three items but assessments could be made shorter still.  Our factor 
analysis suggests two main factors within BI, in keeping with previous descriptions. 29  There 
is a literature describing utility of single question assessments for certain disease states. 30  
 
Having suggested a promising 3-item SF-BI, the next step would be to use this short form 
assessment and describe if it offers any benefit over traditional BI in terms of feasibility, 
acceptability and completion rates.  We speculate that a 3-item SF-BI will lessen assessment 
time, lessen test burden for patients and lead to fewer data transcription errors but all of 
this remains to be proven.  We are encouraged that large audits, registries and clinical trials 
are already incorporating SF-BI into their test batteries and we would encourage any groups 
using the short form to share their experiences with the stroke community.  
 
There is emerging best practice guidance on derivation and validation of short forms 
assessments.31  The papers included in our review pre-date this guidance and so the 
variation in conduct and reporting across the studies is understandable.  There is no 
consensus tool for “quality” assessment of such studies.  We felt, as a minimum, papers 
should describe their derivation cohort and method; use at least two differing validation 
techniques and have further validation in an independent dataset.  Few of the SF-BI 
described in the literature fulfilled all these criteria and our VISTA based analysis assists by 
providing robust, multimodal validation in a large, external dataset.  
 
The strengths of our approach include a robust literature search with internal and external 
validity checks and access to a large dataset of study quality data.  The size of the VISTA 
resource allowed us to look at properties of BI with a greater precision than previously 
described.  We recognise that our literature review included a relatively limited scope of 
databases, with no meta-analyses or quality assessment.  The purpose was to discover SF-
BI and our internal checks suggest we achieved this.  A limitation of our study is around 
generalisability of the VISTA population.  VISTA data are from randomised controlled trials 
and participants may not be representative of unselected stroke admissions.  This is less of 
an issue as we propose that the SF-BI be used for audit and research purposes rather than 
individual patient clinical assessment.  Our focus was stroke, as VISTA is a stroke specific 
resource and BI is often used in stroke trials.  We suspect that our SF-BI could be used in 
non-stroke populations.  However, we found few published papers describing SF-BI in non-
stroke settings.  Where data were available properties seemed favourable32 but further 
validation work would be needed before we recommend SF-BI for other conditions.  We 
recognise that validating a short form does not address some of the inherent limitations of 
the BI as measure of ADL33, but the shortened scale should, at least, address the issue of 
efficiency of assessment.  
 
Our data support use of a shortened Barthel for assessment of stroke populations.  Based 
on multi-modal validation analyses, we recommend a three item scale that sums ability to 
transfer, ability to mobilise and bladder control.  We hope that this short form may prove 
useful in future large scale trials, registries and audit.     
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Table 1.Papers describing short forms of the Barthel Index  
 
 
Populations 
assessed 
Derivation 
cohort “n” 
Item reduction 
method 
Validation method 
Tested in external 
dataset 
Bohannon 3-item 
(two papers)14,15 
Stroke unit 
admissions 
251, 275 N/A 
Multiple validation 
analyses 
Validation of Ellul scale 
with modifications 
Cho19  
Acute ischaemic 
stroke 
N/A N/A N/A N/A 
Ellul 3-item9 
Stroke unit 
admissions 
169 
Predictive ability of 
combinations of items 
Unclear Stroke RCT 
Granger 4-item17 
Stroke Rehabilitation 
Outcome Study 
539 
Four items associated 
with independence 
Predictive 
(discriminant) validity 
No 
Hobart 
5,4 and 3-item8 
Neurological 
rehabilitation unit  
844 
Corrected item total 
correlation, effect size 
Multiple validation 
analyses 
Dataset split 50:50 
derivation  validation  
Hseuh 5-item16 
Stroke Unit 
admissions 
125 N/A 
Multiple validation 
analyses 
Validation of the Hobart 
scale 
Lekamwasam 5-
item18 
Medical and 
orthopaedic clinics 
286 Factor analysis 
Correlation with 
standard BI 
Validation of Hobart scale 
(modified) 
 
  
Table 2:Correlation (Spearman’s rho) for each Barthel Index item with total Barthel Index score 
Barthel Index 
attribute 
Day 90 
Acute data 
1.Feeding 0.82 
2.Bathing 0.84 
3.Grooming 0.72 
4.Dressing 0.89 
5.Bowel Control 0.66 
6.Bladder Control 0.70 
7.Toilet Use 0.85 
8.Transfer 0.85 
9.Mobility 0.85 
10.Stairs 0.88 
 
 
  
Table 3:Correlation of various forms of Barthel Index with other outcomes 
Scale BI full 
scale 
Cho  
3-item 
Ellul  
3-item 
Granger 
4-item 
Hobart  
5-item 
Hobart  
4-item 
Hobart  
3-item 
VISTA  
3-item 
BI90 full scale 1.00 0.95 0.90 0.88 0.95 0.94 0.92 0.90 
mRS90 -0.90 -0.89 -0.85 -0.81 -0.90 -0.89 -0.87 -0.85 
NIHSS 90  -0.81 -0.81 -0.74 -0.74 -0.79 -0.79 -0.78 -0.75 
EQ-5D M3 0.53 0.48 0.47 0.42 0.49 0.48 0.48 0.47 
EQ-5D VAS M3 0.24 0.23 0.19 0.17 0.21 0.23 0.21 0.19 
SIS full scale 0.62 0.60 0.52 0.48 0.57 0.58 0.55 0.53 
SSTALD 0.31 0.28 0.28 0.36 0.27 0.28 0.27 0.28 
Cho 3-item 0.95 1.00 0.87 0.88 0.94 0.94 0.91 0.87 
Ellul 3-item 0.89 0.87 1.00 0.85 0.92 0.90 0.90 0.99 
Granger 4-item 0.88 0.88 0.85 1.00 0.83 0.83 0.84 0.85 
Hobart 5-item 0.95 0.94 0.92 0.83 1.00 0.99 0.97 0.92 
Hobart 4-item 0.94 0.94 0.90 0.83 0.99 1.00 0.97 0.91 
Hobart 3-item 0.92 0.91 0.90 0.84 0.97 0.97 1.00 0.90 
VISTA 3-Item 0.90 0.87 1.00 0.85 0.92 0.91 0.90 1.00 
 
Correlation coefficient (rho) between each outcome measure and SF-BI.  For non-
standardised variables spearman rank correlation coefficient was used.  All significant at pre-
specified level (p<0.001).  
BI=Barthel Index; SF-BI=short form Barthel Index; mRS=modified Rankin Scale; 
NIHSS=National Institutes of Health Stroke Scale; EQ-5D=Euro-Qol 5 dimension; 
SIS=Stroke Impact Scale; SSTALD=Sheffield Screening Test for Acquired Language Disorder   
  
Table 4:Association of various forms of Barthel Index at baseline with 90 day outcomes 
Variable mRS NIHSS 
 OR (95%CI) R-Sq C stat OR (95%CI) R-Sq C stat 
BI 1.24 (1.23,1.25) 0.84 0.91 1.08 (1.08,1.085) 0.69 0.83 
Cho 3-item 1.52 (1.49, 1.55) 0.80 0.90 1.26 (1.25,1.28) 0.68 0.83 
Ellul 3-item 1.19 (1.18,1.20) 0.76 0.87 1.07 (1.07,1.07) 0.62 0.80 
Granger 4-item 1.35 (1.33,1.38) 0.85 0.67 1.20 (1.19,1.21) 0.59 0.80 
Hobart 5-item 1.39 (1.36,1.41) 0.82 0.90 1.13 (1.12,1.13) 0.67 0.82 
Hobart 4-item 1.44 (1.41,1.47) 0.81 0.90 1.18 (1.170,1.19) 0.67 0.82 
Hobart 3-item 1.55 (1.51,1.58) 0.78 0.88 1.24 (1.23,1.25) 0.65 0.82 
VISTA 3-item 1.50 (1.47,1.54) 0.76 0.87 1.18 (1.17,1.18) 0.62 0.80 
 
Multivariate ordinal regressions showing the relationships between each SF-BI and outcome 
measures.  Values are odds of better outcome on mRS and NIHSS, adjusted for 
age,sex,stroke type. 
 
